GE Stock Analysis: GE Aerospace | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 306.994m USD | 12M Return: -6.3% | US3696043013 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.36B
EPS Trend: 98.5%
Qual. Beats: 8
Rev. Trend: 18.0%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GE Aerospace (NYSE: GE) is the aerospace business of the former General Electric Company, focused on designing and producing commercial and defense aircraft engines, integrated engine components, electric power, and aircraft systems. The company operates through two reporting segments: Commercial Engines & Services, which covers jet engines and MRO for commercial airframes, business aviation, and aeroderivative applications, and Defense & Propulsion Technologies, which serves governments, militaries, and commercial airframers with engines, avionics, and power systems. Both segments generate revenue from a mix of original equipment sales and higher-margin aftermarket parts and services, a business model common across large engine OEMs.
The Defense & Propulsion Technologies segment also produces aircraft components and systems, including small turboprops, mechanical transmissions, turbines, combustors and controls, additive-manufactured parts, propeller systems, ignition systems, and engine accessories, marketed under the Avio Aero, Unison, Dowty Propellers, and Colibrium Additive brands for fixed-wing and rotorcraft applications. GE Aerospace operates globally across the United States, Europe, Asia, the Americas, the Middle East, and Africa, and competes in the GICS Aerospace & Defense sub-industry alongside other major engine manufacturers and Tier-1 suppliers.
General Electric Company was incorporated in 1892 and is headquartered in Evendale, Ohio. GE trades as a mega-cap stock in the Industrials sector following the 2024 separation of its power (GE Vernova) and healthcare (GE HealthCare) businesses, which left GE Aerospace as a standalone, pure-play aerospace and defense company.
- Aftermarket services revenue drives margin expansion
- Defense backlog grows with rising military spending
- LEAP engine deliveries ramp with narrowbody recovery
| Net Income: 9.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.19 > 1.0 |
| NWC/Revenue: -1.65% < 20% (prev 3.99%; Δ -5.64% < -1%) |
| CFO/TA 0.07 > 3% & CFO 9.40b > Net Income 9.10b |
| Net Debt (12.5b) to EBITDA (12.8b): 0.98 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.04b) vs 12m ago -2.44% < -2% |
| Gross Margin: 35.23% > 18% (prev 37.79%; Δ -2.56% > 0.5%) |
| Asset Turnover: 41.17% > 50% (prev 34.30%; Δ 6.87% > 0%) |
| Interest Coverage Ratio: 12.51 > 6 (EBIT TTM 11.6b / Interest Expense TTM 926.0m) |
| A: -0.01 (Total Current Assets 41.5b - Total Current Liabilities 42.4b) / Total Assets 127b |
| B: 0.73 (Retained Earnings 92.8b / Total Assets 127b) |
| C: 0.09 (EBIT TTM 11.6b / Avg Total Assets 128b) |
| D: 0.16 (Book Value of Equity 17.5b / Total Liabilities 109b) |
| Altman-Z'' = 3.11 = A |
| DSRI: 0.85 (Receivables 14.0b/13.8b, Revenue 52.6b/44.0b) |
| GMI: 1.07 (GM 37.79% / 35.23%) |
| AQI: 0.95 (AQ_t 0.61 / AQ_t-1 0.64) |
| SGI: 1.20 (Revenue 52.6b / 44.0b) |
| TATA: -0.00 (NI 9.10b - CFO 9.40b) / TA 127b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 25, 2026, the stock is trading at USD 285.64 with a total of 6,516,403 shares traded. Over the past week, the price has changed by -8.98%, over one month by -10.55%, over three months by -18.03% and over the past year by -6.27%.
Current recommended Stop Loss: 273.10 (which is 4.4% or 1.4 ATR below the current price).
GE Aerospace has received a consensus analysts rating of 4.48. Therefore, it is recommended to buy GE.
- StrongBuy: 16
- Buy: 3
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 387 | 35.5% |
P/E Trailing = 34.8915
P/E Forward = 35.3357
P/S = 6.0624
P/B = 18.7761
P/EG = 4.0588
Revenue TTM = 52.6b USD
EBIT TTM = 11.6b USD
EBITDA TTM = 12.8b USD
Long Term Debt = 18.8b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.33b USD (from shortTermDebt, last quarter)
Debt = 21.3b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.97b
Net Debt = 12.5b USD (calculated: Debt 21.3b - CCE 8.76b)
Enterprise Value = 320b USD (307b + Debt 21.3b - CCE 8.76b)
Interest Coverage Ratio = 12.51 (Ebit TTM 11.6b / Interest Expense TTM 926.0m)
EV/FCF = 40.13x (Enterprise Value 320b / FCF TTM 7.96b)
FCF Yield = 2.49% (FCF TTM 7.96b / Enterprise Value 320b)
FCF Margin = 15.15% (FCF TTM 7.96b / Revenue TTM 52.6b)
Net Margin = 17.31% (Net Income TTM 9.10b / Revenue TTM 52.6b)
Gross Margin = 35.23% ((Revenue TTM 52.6b - Cost of Revenue TTM 34.1b) / Revenue TTM)
Gross Margin QoQ = 35.57% (prev 35.03%)
Tobins Q-Ratio = 2.51 (Enterprise Value 320b / Total Assets 127b)
Interest Expense / Debt = 4.35% (Interest Expense 926.0m / Debt 21.3b)
Taxrate = 13.46% (1.43b / 10.7b)
NOPAT = 10.0b (EBIT 11.6b * (1 - 13.46%))
Current Ratio = 0.98 (Total Current Assets 41.5b / Total Current Liabilities 42.4b)
Debt / Equity = 1.22 (Debt 21.3b / totalStockholderEquity, last quarter 17.5b)
Debt / EBITDA = 0.98 (Net Debt 12.5b / EBITDA 12.8b)
Debt / FCF = 1.57 (Net Debt 12.5b / FCF TTM 7.96b)
Total Stockholder Equity = 18.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.13% (Net Income 9.10b / Total Assets 127b)
RoE = 50.64% (Net Income TTM 9.10b / Total Stockholder Equity 18.0b)
RoCE = 31.49% (EBIT 11.6b / Capital Employed (Equity 18.0b + L.T.Debt 18.8b))
RoIC = 11.86% (NOPAT 10.0b / Invested Capital 84.5b)
WACC = 8.98% (E(307b)/V(328b) * Re(9.34%) + D(21.3b)/V(328b) * Rd(4.35%) * (1-Tc(0.13)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.12 | Cagr: -2.42%
[DCF] Terminal Value 75.96% ; FCFF base≈7.38b ; Y1≈8.46b ; Y5≈12.4b
[DCF] Fair Price = 150.5 (EV 169b - Net Debt 12.5b = Equity 156b / Shares 1.04b; r=8.98% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.48 | EPS CAGR: 41.67% | SUE: 2.78 | # QB: 8
Revenue Correlation: 18.04 | Revenue CAGR: 2.02% | SUE: 0.96 | # QB: 2
EPS current Quarter (2027-03-31): EPS=2.10 | Chg30d=+0.42% | Revisions=+40% | Analysts=8
EPS current Year (2026-12-31): EPS=8.11 | Chg30d=+2.46% | Revisions=+29% | GrowthEPS=+27.3% | GrowthRev=+19.7%
EPS next Year (2027-12-31): EPS=9.88 | Chg30d=+1.41% | Revisions=+40% | GrowthEPS=+14.4% | GrowthRev=+11.2%
[Analyst] Revisions Ratio: +55% (up=7, down=1)